Trials / Completed
CompletedNCT07506161
Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas
Thermoablation Treatment of Malignant Thyroid Carcinomas
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Premier G Med Cardio Kft · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radiofrequency ablation alone | Ultrasound-guided percutaneous radiofrequency ablation of T1N0M0 papillary thyroid microcarcinomas |
Timeline
- Start date
- 2021-09-09
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2026-04-01
- Last updated
- 2026-04-01
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT07506161. Inclusion in this directory is not an endorsement.